Stakeholder Meeting on PDUFA V Reauthorization

First Page		Document Content
Clinical research Pharmaceuticals policy Prescription Drug User Fee Act Drug development Center for Drug Evaluation and Research Food and Drug Administration Pharmaceutical sciences Pharmacology		Stakeholder Meeting on PDUFA V Reauthorization Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 70,63 KB Share Document on Facebook

	CENTER FOR DRUG EVALUATION AND RESEARCH DRUG SAFETY PRIORITIES 2017 DocID: 1ueGS - View Document
	CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 208573Orig1s000 SUMMARY REVIEW DocID: 1t19G - View Document
	CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 022526Orig1s000 SUMMARY REVIEW DocID: 1sZi5 - View Document
	MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH DocID: 1sPXO - View Document
	Abstract # 2639 Enhanced (Q)SAR Models for Prediction Rodent Carcinogenicity Naomi L. Kruhlak1, Dongyu Guo1, Kevin P. Cross2, Lidiya Stavitskaya1 FDA Center for Drug Evaluation and Research (CDER), 10903 New Hampshire A DocID: 1swgc - View Document